Position in MYGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$131,015
-$244,773 QoQ
Shares Held
22,945
+20.7% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#107
of 197 holders
Holding Since
Mar 2020
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Aigen Investment Management, LP holds $6,325,147 across 7 Diagnostics & Research names. MYGN ranks #7 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MTD |
Mettler Toledo International Inc/
|
2,021 | $2,581,847 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
4,316 | $2,163,869 | |
| 3 | GH |
Guardant Health, Inc.
|
3,104 | $465,693 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
1,987 | $383,928 | |
| 5 | NTRA |
Natera, Inc.
|
1,338 | $363,200 | |
| 6 | TWST |
Twist Bioscience Corp
|
2,290 | $235,595 | |
| 7 | MYGN |
Myriad Genetics Inc
This page
|
22,945 | $131,015 |
All Filings in MYGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $131,015 | 22,945 | Shares | Sole | 2026-08-14 | |
| 2020-12-31 | $375,788 | 19,008 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $906,566 | 69,522 | Shares | Sole | 2020-11-06 | |
| 2020-03-31 | $225,067 | 15,728 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||